273 related articles for article (PubMed ID: 37421458)
1. A novel pyroptosis-related signature predicts prognosis and indicates immunotherapy in oral squamous cell carcinoma.
Gao Y; Zhang X; Li Y; Gao J; Liu S; Cai H; Zhang J
J Cancer Res Clin Oncol; 2023 Oct; 149(13):12057-12070. PubMed ID: 37421458
[TBL] [Abstract][Full Text] [Related]
2. Prognostic model revealing pyroptosis-related signatures in oral squamous cell carcinoma based on bioinformatics analysis.
Qi L; Tang Z
Sci Rep; 2024 Mar; 14(1):6149. PubMed ID: 38480853
[TBL] [Abstract][Full Text] [Related]
3. Bioinformatic analysis and experimental validation of cuproptosis-related LncRNA as a novel biomarker for prognosis and immunotherapy of oral squamous cell carcinoma.
Liang S; Ji L; Yu Z; Cheng Y; Gao R; Yan W; Zhang F
Hereditas; 2024 Feb; 161(1):10. PubMed ID: 38414024
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive analysis of pyroptosis regulation patterns and their influence on tumor immune microenvironment and patient prognosis in glioma.
Fan T; Wan Y; Niu D; Wang B; Zhang B; Zhang Z; Zhang Y; Gong Z; Zhang L
Discov Oncol; 2022 Mar; 13(1):13. PubMed ID: 35274175
[TBL] [Abstract][Full Text] [Related]
5. A novel Pyroptosis-related long non-coding RNA signature for predicting the prognosis and immune landscape of head and neck squamous cell carcinoma.
Zhou C; Shen Y; Jin Y; Shen Z; Ye D; Shen Y; Deng H
Cancer Med; 2022 Dec; 11(24):5097-5112. PubMed ID: 35567376
[TBL] [Abstract][Full Text] [Related]
6. A Novel Immune-Related Gene Signature to Identify the Tumor Microenvironment and Prognose Disease Among Patients With Oral Squamous Cell Carcinoma Patients Using ssGSEA: A Bioinformatics and Biological Validation Study.
Chen Y; Feng Y; Yan F; Zhao Y; Zhao H; Guo Y
Front Immunol; 2022; 13():922195. PubMed ID: 35935989
[TBL] [Abstract][Full Text] [Related]
7. Identification of cuproptosis-related lncRNAs with the significance in prognosis and immunotherapy of oral squamous cell carcinoma.
Gong H; Liu Z; Yuan C; Luo Y; Chen Y; Zhang J; Cui Y; Zeng B; Liu J; Li H; Deng Z
Comput Biol Med; 2024 Mar; 171():108198. PubMed ID: 38417385
[TBL] [Abstract][Full Text] [Related]
8. Construction and validation of a metabolic-related genes prognostic model for oral squamous cell carcinoma based on bioinformatics.
Zhang J; Ma C; Qin H; Wang Z; Zhu C; Liu X; Hao X; Liu J; Li L; Cai Z
BMC Med Genomics; 2022 Dec; 15(1):269. PubMed ID: 36566175
[TBL] [Abstract][Full Text] [Related]
9. Identification and validation of a prognostic signature of autophagy, apoptosis and pyroptosis-related genes for head and neck squamous cell carcinoma: to imply therapeutic choices of HPV negative patients.
Nan Z; Dou Y; Chen A; Wang K; Sun J; Meng Z; Neckenig M; Ai D; Liu S; Dong Z; Ma C; Cheng Y; Qu X
Front Immunol; 2022; 13():1100417. PubMed ID: 36703967
[TBL] [Abstract][Full Text] [Related]
10. A meta-validated immune infiltration-related gene model predicts prognosis and immunotherapy sensitivity in HNSCC.
Ding Y; Chu L; Cao Q; Lei H; Li X; Zhuang Q
BMC Cancer; 2023 Jan; 23(1):45. PubMed ID: 36639648
[TBL] [Abstract][Full Text] [Related]
11. Identification of pyroptosis-related gene prognostic signature in head and neck squamous cell carcinoma.
Li Z; Shen L; Li Y; Shen L; Li N
Cancer Med; 2022 Dec; 11(24):5129-5144. PubMed ID: 35574984
[TBL] [Abstract][Full Text] [Related]
12. Construction of prognostic signature of patients with oral squamous cell carcinoma based on pyroptosis-related long non-coding RNAs.
Xin Y; Zhang J; Jiang Q; Qiu J
Front Surg; 2022; 9():935765. PubMed ID: 36211292
[TBL] [Abstract][Full Text] [Related]
13. Ferroptosis-associated DNA methylation signature predicts overall survival in patients with head and neck squamous cell carcinoma.
Xu Y; Hong M; Kong D; Deng J; Zhong Z; Liang J
BMC Genomics; 2022 Jan; 23(1):63. PubMed ID: 35042463
[TBL] [Abstract][Full Text] [Related]
14. Construction and validation of immune-related LncRNAs classifier to predict prognosis and immunotherapy response in laryngeal squamous cell carcinoma.
Wang X; Pan Y; Ou Y; Duan T; Zou Y; Zhou X
World J Surg Oncol; 2022 May; 20(1):164. PubMed ID: 35606755
[TBL] [Abstract][Full Text] [Related]
15. A novel T-cell proliferation-associated gene predicts prognosis and reveals immune infiltration in patients with oral squamous cell carcinoma.
Cui Y; Cheng Y; Huang W; Liu J; Zhang X; Bu M; Li X
Arch Oral Biol; 2023 Aug; 152():105719. PubMed ID: 37178584
[TBL] [Abstract][Full Text] [Related]
16. A pyroptosis-related lncRNA signature predicts prognosis and immune microenvironment in head and neck squamous cell carcinoma.
Zhu W; Ye Z; Chen L; Liang H; Cai Q
Int Immunopharmacol; 2021 Dec; 101(Pt B):108268. PubMed ID: 34688154
[TBL] [Abstract][Full Text] [Related]
17. An immune cell infiltration landscape classification to predict prognosis and immunotherapy effect in oral squamous cell carcinoma.
Yang Z; He F
Comput Methods Biomech Biomed Engin; 2024; 27(2):191-203. PubMed ID: 36794748
[TBL] [Abstract][Full Text] [Related]
18. FCGBP Is a Promising Prognostic Biomarker and Correlates with Immunotherapy Efficacy in Oral Squamous Cell Carcinoma.
Shen T; Zhang J; Wang Y; Liu B
J Immunol Res; 2022; 2022():8443392. PubMed ID: 35733916
[TBL] [Abstract][Full Text] [Related]
19. Development of a lncRNA-based prognostic signature for oral squamous cell carcinoma.
Xu Z; Li X; Pan L; Tan R; Ji P; Tang H
J Oral Pathol Med; 2022 Apr; 51(4):358-368. PubMed ID: 35100473
[TBL] [Abstract][Full Text] [Related]
20. A four-hypoxia-genes-based prognostic signature for oral squamous cell carcinoma.
Zhao C; Zhou Y; Ma H; Wang J; Guo H; Liu H
BMC Oral Health; 2021 May; 21(1):232. PubMed ID: 33941139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
